A total of 42,866 of patients with a formal diagnosis of Bell’s palsy were identified with 39,292 (92%) adults and 3,754 (8%) children (< 18 years old), respectively. Steroids were provided to 50.1% of children and 59.8% of adults and antivirals were prescribed to 26.2 and 39.4% of the children and adults, respectively.
Trends in the Treatment of Bell’s Palsy
Tom Shokri 1, Robert Saadi 1, Eric W Schaefer 2, Jessyka G Lighthall 3Affiliations expand
- PMID: 32791532
- DOI: 10.1055/s-0040-1713808
Abstract
The aim of the study is to: (1) evaluate national trends in care of facial paralysis, namely Bell’s palsy, patients to identify the types of treatments patients are receiving and treatment gaps and (2) identify if newer, more complex surgical therapies published in the literature are being employed. Data were collected from the MarketScan Commercial Claims and Encounters Database by Truven Health. From the database, all inpatient and outpatient claims with International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes for facial paralysis/dysfunction between 2005 and 2013 were extracted. Trends in medical and surgical management were evaluated specifically cataloging the use of steroids, antivirals, botulinum toxin, surgical and rehabilitation service current procedural terminology codes. A total of 42,866 of patients with a formal diagnosis of Bell’s palsy were identified with 39,292 (92%) adults and 3,754 (8%) children (< 18 years old), respectively. Steroids were provided to 50.1% of children and 59.8% of adults and antivirals were prescribed to 26.2 and 39.4% of the children and adults, respectively. Within the first 2 years after diagnosis, 0.5% of children and 0.9% of adults received surgery, 0.1% of children and 0.8% of adults received botulinum toxin treatments, and 10.9% of children and 21.5% of adults received rehabilitation services. Despite the limitations of a claims database study, results showing trends in care of facial paralysis are still nonsurgical with many patients receiving no treatment at all. Although limited literature has shown an increase in the use of pharmacotherapy as well as techniques including physiotherapy, chemodenervation, and various surgical therapies, these interventions may be underutilized.
Thieme. All rights reserved.
Conflict of interest statement
None declared.
Similar articles
- The benefits of steroids versus steroids plus antivirals for treatment of Bell’s palsy: a meta-analysis.Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY.BMJ. 2009 Sep 7;339:b3354. doi: 10.1136/bmj.b3354.PMID: 19736282 Free PMC article. Review.
- Antiviral treatment for Bell’s palsy (idiopathic facial paralysis).Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F.Cochrane Database Syst Rev. 2015 Nov 9;(11):CD001869. doi: 10.1002/14651858.CD001869.pub8.PMID: 26559436 Review.
- Antiviral treatment for Bell’s palsy (idiopathic facial paralysis).Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F.Cochrane Database Syst Rev. 2015 Jul 1;(7):CD001869. doi: 10.1002/14651858.CD001869.pub6.PMID: 26130372 Updated. Review.
- WITHDRAWN. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis).Gagyor I, Madhok VB, Daly F, Somasundara D, Sullivan M, Gammie F, Sullivan F.Cochrane Database Syst Rev. 2015 May 4;(5):CD001869. doi: 10.1002/14651858.CD001869.pub5.PMID: 25938618 Updated. Review.
- Clinical practice guideline: Bell’s palsy.Baugh RF, Basura GJ, Ishii LE, Schwartz SR, Drumheller CM, Burkholder R, Deckard NA, Dawson C, Driscoll C, Gillespie MB, Gurgel RK, Halperin J, Khalid AN, Kumar KA, Micco A, Munsell D, Rosenbaum S, Vaughan W.Otolaryngol Head Neck Surg. 2013 Nov;149(3 Suppl):S1-27. doi: 10.1177/0194599813505967.PMID: 24189771
Editor do blog: Julio Pereira – Neurocirugião – São Paulo CRM/SP 163.113 Site para Consulta: https://www.julio-pereira.com/ Consultório: (11)99503-8838 (WhatsApp) / (11)4200-2300 Atuando no Hospital Sírio-Libanês e na BP – A Beneficência Portuguesa de São Paulo.